Stockreport

Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023 [Yahoo! Finance]

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Research and Development: R&D expenses dropped to $26.8 million in Q4, down from $46.2 million in Q4 2022. General and Administrative Expenses: G&A expenses were $17. [Read more]